Federal Agency Halts Studies of Hydroxychloroquine, Drug Trump Promoted June 20, 2020 NYT > Top Stories The National Institutes of Health decided to stop one trial because the drug was unlikely to benefit patients, and another because not enough people enrolled. from NYT > Top Stories https://ift.tt/37MztyB Author : Unknown Share this Related Posts
EmoticonEmoticon